DOCSLIB.ORG

Fribourg 1+2.Pptx

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Fribourg 1+2.Pptx T Kaufmann ‐ Apoptosis (1+2) Nov 16 2009 Apoptosis: Mechanisms, Techniques &Therapeuc Targets Thomas Kaufmann Instute of Pharmacology University of Bern [email protected] www.pki.unibe.ch Contents 1 & 2 3 & 4 3 & 4 7 & 8 • Necrosis • Caspases • Bcl‐2 Family • Apoptosis in • Apoptosis • Acvaon of Proteins Disease • Main • Detecon • Death • Therapeuc Apoptoc Receptors Targets Pathways 2009 T Kaufmann ‐ Apoptosis (1+2) 2 STRESS steady state normal physiological funcon increased (physiological) adaptaon excessive cellular damage CELL DEATH 2009 T Kaufmann ‐ Apoptosis (1+2) 3 1 T Kaufmann ‐ Apoptosis (1+2) Nov 16 2009 Cellular Adaptaon to Stress Atrophy • Reducon in cell size and funcon Hypertrophy • Increase in cell size and funcon Hyperplasia • Increase in cell number • Replacement by a more stress resistant cell Metaplasia type • Change of size, form and organisaon Dysplasia • Start of neoplasc transformaons • Genec component; clonal 2009 T Kaufmann ‐ Apoptosis (1+2) 4 Cellular stress and damage is reversible up to a certain point: point‐of‐no‐return Cell Death 2009 T Kaufmann ‐ Apoptosis (1+2) 5 Happy Stressed Cellular Adaptaon cell cell Cellular Damage CELL DEATH 2009 T Kaufmann ‐ Apoptosis (1+2) 6 2 T Kaufmann ‐ Apoptosis (1+2) Nov 16 2009 All forms of ssue damage start with damaged single cells necroc cell 2009 T Kaufmann ‐ Apoptosis (1+2) 7 Two Main Forms of Cell Death 2009 T Kaufmann ‐ Apoptosis (1+2) 8 Outdated Concept… Apoptosis Necrosis programmed physiological cell death Accidenal acve pathological regulated passive “good” cellular lysis “bad“ 2009 T Kaufmann ‐ Apoptosis (1+2) 9 3 T Kaufmann ‐ Apoptosis (1+2) Nov 16 2009 PROGRAMMED CELL DEATH Apoptosis Pyroptosis Autophagic Cell Death Pyronecrosis Necroptosis (Pro‐ Cornificaon grammed Necrosis) NECROTIC CELL DEATH 2009 T Kaufmann ‐ Apoptosis (1+2) 10 When is a Cell Dead? When the researcher says so (?) In vitro In vivo • Loss of plasma membrane • Cell (or its fragments) has integrity been engulfed by adjacent and/or cells • Complete fragmentaon of cell and/or nucleus in discrete bodies and/or • Degradaon/fragmentaon of genomic DNA 2009 T Kaufmann ‐ Apoptosis (1+2) 11 Necrosis • Classical Necrosis is always pathological • Passive form of cell death resulng from irreversible cellular damage • Energy independent • Lysis of the cell membrane (and organelles) • Oen whole parts of ssue/organ affected • Triggers inflammatory reacons 2009 T Kaufmann ‐ Apoptosis (1+2) 12 4 T Kaufmann ‐ Apoptosis (1+2) Nov 16 2009 Classical Necroc Stresses • Lack of energy(/blood/oxygen) supply (ischemia) ‐> lack of energy producon • Chemical Stress: azide, inhibitors of respiratory chain many chemodrugs (high doses) oxygen radicals ‐> membrane damage, protein oxidaon • Physical Stress: strong radiaon (UV, γ), heat, cold 2009 T Kaufmann ‐ Apoptosis (1+2) 13 haemorrhagic infarct Severe myocardial ischemic infarct 2009 T Kaufmann ‐ Apoptosis (1+2) 14 • The nature and/or the intensity of the stress determines how a cell dies Stress X Stress Y Healthy Apoptosis Necrosis e.g. γ‐radiaon 2009 T Kaufmann ‐ Apoptosis (1+2) 15 5 T Kaufmann ‐ Apoptosis (1+2) Nov 16 2009 Necrosis Physical damage Chemical ATP depleon damage Cellular homeostasis↓ Membrane potenal↓ Membrane/ energy↓ organelle damage Ion channels↓ Calcium↑ Lysis of cell H20↑ Cellular volume↑ Inflammaon 2009 T Kaufmann ‐ Apoptosis (1+2) 16 Stages of Necrosis F. Chan, Worcester 2009 T Kaufmann ‐ Apoptosis (1+2) 17 Necrosis S. Marn, Dublin 2009 T Kaufmann ‐ Apoptosis (1+2) 18 6 T Kaufmann ‐ Apoptosis (1+2) Nov 16 2009 Morphological Disncons of Necrosis Fat Tissue „Stress“ Necrosis Acvaon of lipases Irreversible Cellular Damage Microbial Denaturing of proteins degradaon (heat/cold/acids) Enzymac degradaon Coagulave Necrosis Caseous Necrosis Colliquave Necrosis „Mummificaon“ Gangrene „Liquefacon“ Putrefacon 2009 T Kaufmann ‐ Apoptosis (1+2) 19 Fat ssue necrosis (acute pancreas) 2009 T Kaufmann ‐ Apoptosis (1+2) 20 Coagulave necrosis (skeletal muscle) 2009 T Kaufmann ‐ Apoptosis (1+2) 21 7 T Kaufmann ‐ Apoptosis (1+2) Nov 16 2009 Caseous Necrosis (“Käsige Nekrose”) in lung from tuberculosis paent ‐> “Cheese‐like” appearance of granuloma – typical and only seen in tuberculosis 2009 T Kaufmann ‐ Apoptosis (1+2) 22 Apoptosis • Physiological AND pathophysiological form of cell death • Programmed cell death • Evoluonary conservaon • Highly regulated and energy‐consuming process • Cells remain intact no inflammatory • Rapid phagocytosis (in vivo) response • Inducon of Tolerance • Fragmentaon of genomic DNA • Oen single cell death 2009 T Kaufmann ‐ Apoptosis (1+2) 23 Morphological Changes during Apoptosis 2009 T Kaufmann ‐ Apoptosis (1+2) 24 8 T Kaufmann ‐ Apoptosis (1+2) Nov 16 2009 Apoptosis S Marn, Dublin 2009 T Kaufmann ‐ Apoptosis (1+2) 25 “Death by Default” (M. Raff, 1992) • Every nucleated cell of our body is programmed to die <=> cell has to be kept alive constantly Pro‐ Pro‐ apoptoc survival Sm X Stress A cell Sm Y Cell Stress B Sm Z 2009 T Kaufmann ‐ Apoptosis (1+2) 26 Inducon of Apoptosis • DNA‐damaging radiaon (UVR, • Growth factor (cytokine) IR) withdrawal • Most chemodrugs • ‘death‐by‐neglect’ (thymocytes) • Viral Infecons (hepas, HIV) • Cell detachment induced death • Inflammaon, sepsis (Anoikis) • Transplant rejecon • Loss of nerve cell connecons • Negave selecon (thymocytes) • Steroids • Oxygen stress 2009 T Kaufmann ‐ Apoptosis (1+2) 27 9 T Kaufmann ‐ Apoptosis (1+2) Nov 16 2009 Apoptotic Cell Death is Essential in a Healthy Organism • Development (embryogenesis) • Tissue homeostasis of adult organism • Shaping of immune repertoire • Terminaon of immune response ‐> apoptosis guarantees the safe re‐ moval of old, unwanted or poten‐ ally dangerous cells 2009 T Kaufmann ‐ Apoptosis (1+2) 28 A) Apoptosis in Development Removal of interdigital webs Syndactyly Hutcheson et al. JEM 2005 2009 T Kaufmann ‐ Apoptosis (1+2) 29 Development of the brain ca. half of the neurons (~ 1012 !) inially produced in the nervous system will be removed by apoptosis during development wildtype apaf‐1‐/‐ Yoshida et al, Cell 1998 2009 T Kaufmann ‐ Apoptosis (1+2) 30 10 T Kaufmann ‐ Apoptosis (1+2) Nov 16 2009 B) Tissue Homeostasis ~ 1 x 1014 cells ~ 200 cell types > 1 x 106 cells turned over per second! • Colon epithelium – Shedded off every 3 days 2009 T Kaufmann ‐ Apoptosis (1+2) 31 • Haematopoiec system ‐> ca. 0.85 x 109 neutrophilic granulocytes (neutrophils) produced every day per kg body weight! Male of 80 kg: 8x1010/day ca. 8x105/second! Half‐life in blood ca 12 hours 2009 T Kaufmann ‐ Apoptosis (1+2) 32 C) Shaping of Immune System • B Cell Maturaon Strasser A, Nat Rev Immunol 2005 2009 T Kaufmann ‐ Apoptosis (1+2) 33 11 T Kaufmann ‐ Apoptosis (1+2) Nov 16 2009 • T Cell Maturaon Strasser A, Nat Rev Immunol 2005 healthy thymus (mouse): ca 20% dead thymocytes 2009 T Kaufmann ‐ Apoptosis (1+2) 34 D) Terminaon of Immune Response Effector cell apoptosis Effector cell expansion Viral killing Viral replicaon CD8 T‐cell numbers Viral clearance CTL response Viral tre Infecon Time post infecon Pellegrini et al., TCB 2004 2009 T Kaufmann ‐ Apoptosis (1+2) 35 Aberrant Apoptosis is a Cause or Consequence of Many Diseases • too much apoptosis • too lile apoptosis – Auommune disorders (e.g. pancreac β‐cells) – CANCER – HIV (CD4+) – Hepas (viral, alcohol – Autoimmune disorders induced, …) – Sepsis (immuno‐ suppressed state) – Viral diseases (e.g. EBV) – Neurodegeneraon – Radiaon damage (skin, bone marrow, stem cells) 2009 T Kaufmann ‐ Apoptosis (1+2) 36 12 T Kaufmann ‐ Apoptosis (1+2) Nov 16 2009 Autoimmunity • Too much apoptosis in healthy cells/ssues • Not enough apoptosis in immune effector cells 2009 T Kaufmann ‐ Apoptosis (1+2) 37 CTL‐Mediated Tissue Damage CTL (CD8+ T cell) Target cell P/G Perforin/Granzymes FasL FasL Fas CTL Target cell 2009 T Kaufmann ‐ Apoptosis (1+2) 38 Perforin/ Granzyme System Voskoboinik et al. Nat Rev Imm 2006 2009 T Kaufmann ‐ Apoptosis (1+2) 39 13 T Kaufmann ‐ Apoptosis (1+2) Nov 16 2009 Gra‐vs‐Host Disease acute GvHD, skin Bone Marrow Transplantaon (2008) 41, 1029–1035 CD8+ acute GvHD, colon 2009 T Kaufmann ‐ Apoptosis (1+2) 40 ALPS (autoimmune lymphoproliferave syndrome) Reduced T and B lymphocyte apoptosis 2009 T Kaufmann ‐ Apoptosis (1+2) 41 Cancer Hanahan & Weinberg, Cell 2000 2009 T Kaufmann ‐ Apoptosis (1+2) 42 14 T Kaufmann ‐ Apoptosis (1+2) Nov 16 2009 Cancer • Bcl‐2 staining of paraffin embedded human breast carcinoma secon (Epitomics) 2009 T Kaufmann ‐ Apoptosis (1+2) 43 Polyp (Colon Mucosa) 2009 T Kaufmann ‐ Apoptosis (1+2) 44 Necrosis Triggers Inflammatory Responses infiltrang neutrophils in necroc ssue (contracon band necrosis) 2009 T Kaufmann ‐ Apoptosis (1+2) 45 15 T Kaufmann ‐ Apoptosis (1+2) Nov 16 2009 Phagocytosis of Apoptoc Cells Prevents Inflammaon 2009 T Kaufmann ‐ Apoptosis (1+2) 46 Find‐Me Signals 2009 T Kaufmann ‐ Apoptosis (1+2) 47 Find‐Me Signals • ATP, UTP <‐> P2Y2 (G‐Protein coupled receptor) • CX3CL1 <‐> CX3CR1 • Lysophosphadylcholine (LPC) <‐> G2A 2009 T Kaufmann ‐ Apoptosis (1+2) 48 16 T Kaufmann ‐ Apoptosis (1+2) Nov 16 2009 Eat‐Me Signals • Apoptoc cells display “eat‐me signals” on their surface ‐> phagocytosis by professional phagocytes (mainly macrophages) Ravichandran et al, Nat Rev Immunol 2007 2009 T Kaufmann ‐ Apoptosis (1+2) 49 Macrophage with engulfed apoptoc cells (red) 2009 T Kaufmann ‐ Apoptosis (1+2) 50 Redistribuon of Phosphadylserine in the Plasma Membrane Lipid Bilayer AnnexinV outer leaflet inner leaflet healthy apoptoc PS (phosphadylserine) 2009 T Kaufmann ‐ Apoptosis (1+2) 51 17 T Kaufmann
Load more

Recommended publications
  • Mycobacterium Tuberculosis Scott M
    © 2015. Published by The Company of Biologists Ltd | Disease Models & Mechanisms (2015) 8, 591-602 doi:10.1242/dmm.019570 RESEARCH ARTICLE Presence of multiple lesion types with vastly different microenvironments in C3HeB/FeJ mice following aerosol infection with Mycobacterium tuberculosis Scott M. Irwin1, Emily Driver1, Edward Lyon1, Christopher Schrupp1, Gavin Ryan1, Mercedes Gonzalez-Juarrero1, Randall J. Basaraba1, Eric L. Nuermberger2 and Anne J. Lenaerts1,* ABSTRACT reservoir (Lin and Flynn, 2010). Since 2008, the incidence of Cost-effective animal models that accurately reflect the pathological multiple-drug-resistant (MDR) tuberculosis (TB) in Africa has progression of pulmonary tuberculosis are needed to screen and almost doubled, while in southeast Asia the incidence has increased evaluate novel tuberculosis drugs and drug regimens. Pulmonary more than 11 times (World Health Organization, 2013). Globally, disease in humans is characterized by a number of heterogeneous the incidence of MDR TB increased 42% from 2011 to 2012, with lesion types that reflect differences in cellular composition and almost 10% of those cases being extensively drug-resistant (XDR) organization, extent of encapsulation, and degree of caseous TB. With the rise in MDR and XDR TB, new drugs and especially necrosis. C3HeB/FeJ mice have been increasingly used to model drugs with a novel mechanism of action or drugs that can shorten the tuberculosis infection because they produce hypoxic, well-defined duration of treatment are desperately needed. granulomas
    [Show full text]
  • A Case of Lupus Vulgaris Carmen D
    Symmetrically Distributed Orange Eruption on the Ears: A Case of Lupus Vulgaris Carmen D. Campanelli, BS, Wilmington, Delaware Anthony F. Santoro, MD, Philadelphia, Pennsylvania Cynthia G. Webster, MD, Hockessin, Delaware Jason B. Lee, MD, New York, New York Although the incidence and morbidity of tuberculo- sis (TB) have declined in the latter half of the last decade in the United States, the number of cases of TB (especially cutaneous TB) among those born outside of the United States has increased. This discrepancy can be explained, in part, by the fact that cutaneous TB can have a long latency period in those individuals with a high degree of immunity against the organism. In this report, we describe an individual from a region where there is a rela- tively high prevalence of tuberculosis who devel- oped lupus vulgaris of the ears many years after arrival to the United States. utaneous tuberculosis (TB) is a rare manifes- tation of Mycobacterium tuberculosis infection. C Scrofuloderma, TB verrucosa cutis, and lupus vulgaris (LV) comprise most of the cases of cutaneous TB. All 3 are rarely encountered in the United States. During the last several years, the incidence of TB has declined in the United States, but the incidence of these 3 types of cutaneous TB has increased in foreign-born individuals. This discrepancy can be ex- plained, in part, by the fact that TB can have a long latency period, especially in those individuals with a Figure 1. Orange plaques and nodules on the right ear. high degree of immunity against the organism. Indi- viduals from regions where there is a high prevalence Case Report of TB may develop cutaneous TB many years after ar- A 71-year-old man from the Philippines presented rival to the United States, despite screening protocol with an eruption on both ears that had existed for when they enter the United States.
    [Show full text]
  • HIV Infection and AIDS
    G Maartens 12 HIV infection and AIDS Clinical examination in HIV disease 306 Prevention of opportunistic infections 323 Epidemiology 308 Preventing exposure 323 Global and regional epidemics 308 Chemoprophylaxis 323 Modes of transmission 308 Immunisation 324 Virology and immunology 309 Antiretroviral therapy 324 ART complications 325 Diagnosis and investigations 310 ART in special situations 326 Diagnosing HIV infection 310 Prevention of HIV 327 Viral load and CD4 counts 311 Clinical manifestations of HIV 311 Presenting problems in HIV infection 312 Lymphadenopathy 313 Weight loss 313 Fever 313 Mucocutaneous disease 314 Gastrointestinal disease 316 Hepatobiliary disease 317 Respiratory disease 318 Nervous system and eye disease 319 Rheumatological disease 321 Haematological abnormalities 322 Renal disease 322 Cardiac disease 322 HIV-related cancers 322 306 • HIV INFECTION AND AIDS Clinical examination in HIV disease 2 Oropharynx 34Neck Eyes Mucous membranes Lymph node enlargement Retina Tuberculosis Toxoplasmosis Lymphoma HIV retinopathy Kaposi’s sarcoma Progressive outer retinal Persistent generalised necrosis lymphadenopathy Parotidomegaly Oropharyngeal candidiasis Cytomegalovirus retinitis Cervical lymphadenopathy 3 Oral hairy leucoplakia 5 Central nervous system Herpes simplex Higher mental function Aphthous ulcers 4 HIV dementia Kaposi’s sarcoma Progressive multifocal leucoencephalopathy Teeth Focal signs 5 Toxoplasmosis Primary CNS lymphoma Neck stiffness Cryptococcal meningitis 2 Tuberculous meningitis Pneumococcal meningitis 6
    [Show full text]
  • Chapter 1 Cellular Reaction to Injury 3
    Schneider_CH01-001-016.qxd 5/1/08 10:52 AM Page 1 chapter Cellular Reaction 1 to Injury I. ADAPTATION TO ENVIRONMENTAL STRESS A. Hypertrophy 1. Hypertrophy is an increase in the size of an organ or tissue due to an increase in the size of cells. 2. Other characteristics include an increase in protein synthesis and an increase in the size or number of intracellular organelles. 3. A cellular adaptation to increased workload results in hypertrophy, as exemplified by the increase in skeletal muscle mass associated with exercise and the enlargement of the left ventricle in hypertensive heart disease. B. Hyperplasia 1. Hyperplasia is an increase in the size of an organ or tissue caused by an increase in the number of cells. 2. It is exemplified by glandular proliferation in the breast during pregnancy. 3. In some cases, hyperplasia occurs together with hypertrophy. During pregnancy, uterine enlargement is caused by both hypertrophy and hyperplasia of the smooth muscle cells in the uterus. C. Aplasia 1. Aplasia is a failure of cell production. 2. During fetal development, aplasia results in agenesis, or absence of an organ due to failure of production. 3. Later in life, it can be caused by permanent loss of precursor cells in proliferative tissues, such as the bone marrow. D. Hypoplasia 1. Hypoplasia is a decrease in cell production that is less extreme than in aplasia. 2. It is seen in the partial lack of growth and maturation of gonadal structures in Turner syndrome and Klinefelter syndrome. E. Atrophy 1. Atrophy is a decrease in the size of an organ or tissue and results from a decrease in the mass of preexisting cells (Figure 1-1).
    [Show full text]
  • LL-37 Immunomodulatory Activity During Mycobacterium Tuberculosis Infection in Macrophages
    LL-37 Immunomodulatory Activity during Mycobacterium tuberculosis Infection in Macrophages Flor Torres-Juarez,a Albertina Cardenas-Vargas,a Alejandra Montoya-Rosales,a Irma González-Curiel,a Mariana H. Garcia-Hernandez,a a b a Jose A. Enciso-Moreno, Robert E. W. Hancock, Bruno Rivas-Santiago Downloaded from Medical Research Unit-Zacatecas, Mexican Institute for Social Security-IMSS, Zacatecas, Mexicoa; Centre for Microbial Diseases and Immunity Research, University of British Columbia, Vancouver, BC, Canadab Tuberculosis is one of the most important infectious diseases worldwide. The susceptibility to this disease depends to a great extent on the innate immune response against mycobacteria. Host defense peptides (HDP) are one of the first barriers to coun- teract infection. Cathelicidin (LL-37) is an HDP that has many immunomodulatory effects besides its weak antimicrobial activ- ity. Despite advances in the study of the innate immune response in tuberculosis, the immunological role of LL-37 during M. tuberculosis infection has not been clarified. Monocyte-derived macrophages were infected with M. tuberculosis strain H37Rv http://iai.asm.org/ and then treated with 1, 5, or 15 ␮g/ml of exogenous LL-37 for 4, 8, and 24 h. Exogenous LL-37 decreased tumor necrosis factor alpha (TNF-␣) and interleukin-17 (IL-17) while inducing anti-inflammatory IL-10 and transforming growth factor ␤ (TGF-␤) production. Interestingly, the decreased production of anti-inflammatory cytokines did not reduce antimycobacterial activity. These results are consistent with the concept that LL-37 can modulate the expression of cytokines during mycobacterial infec- tion and this activity was independent of the P2X7 receptor. Thus, LL-37 modulates the response of macrophages during infec- tion, controlling the expression of proinflammatory and anti-inflammatory cytokines.
    [Show full text]
  • Diagnosis of Tubercular Lymphadenopathy by Fine Needle Aspiration Cytology and Z-N Staining
    International Journal of Research in Medical Sciences Naz N et al. Int J Res Med Sci. 2019 Aug;7(8):2985-2988 www.msjonline.org pISSN 2320-6071 | eISSN 2320-6012 DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20193382 Original Research Article Diagnosis of tubercular lymphadenopathy by fine needle aspiration cytology and Z-N staining Navneet Naz, Megha Sharma* Department of Pathology, Government Medical College Jammu, Jammu and Kashmir, India Received: 14 March 2019 Revised: 30 June 2019 Accepted: 10 July 2019 *Correspondence: Dr. Megha Sharma, E-mail: [email protected] Copyright: © the author(s), publisher and licensee Medip Academy. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. ABSTRACT Background: Tuberculosis continues to be the biggest health problem in India. Tuberculosis involves respiratory, gastrointestinal tract as well as extrapulmonary site. Tubercular lymphadenopathy is the most common form of extrapulmonary tuberculosis. FNAC plays a vital role in diagnosis of tubercular lymphadenopathy. FNAC is not only used for cytological diagnosis but also used for other ancillary tests like Ziehl-Neelsen staining and AFB culture. Methods: The study was conducted in the department of pathology, Government Medical College, Jammu over a period of 6 months and included 450 cases presenting with superficial lymphadenopathy. FNAC was performed in the cases and smears in each case, were stained with May Grunwald Giemsa (MGG), Papanicolaou and Z-N stain. Results: Out of 450 cases,160 cases (35.5%) showed features of tubercular lymphadenitis.
    [Show full text]
  • Urogenital Tuberculosis — Epidemiology, Pathogenesis and Clinical Features
    REVIEWS Urogenital tuberculosis — epidemiology, pathogenesis and clinical features Asif Muneer1, Bruce Macrae2, Sriram Krishnamoorthy3 and Alimuddin Zumla2,4,5* Abstract | Tuberculosis (TB) is the most common cause of death from infectious disease worldwide. A substantial proportion of patients presenting with extrapulmonary TB have urogenital TB (UG-TB), which can easily be overlooked owing to non-specific symptoms, chronic and cryptic protean clinical manifestations, and lack of clinician awareness of the possibility of TB. Delay in diagnosis results in disease progression, irreversible tissue and organ damage and chronic renal failure. UG-TB can manifest with acute or chronic inflammation of the urinary or genital tract, abdominal pain, abdominal mass, obstructive uropathy, infertility, menstrual irregularities and abnormal renal function tests. Advanced UG-TB can cause renal scarring, distortion of renal calyces and pelvic, ureteric strictures, stenosis, urinary outflow tract obstruction, hydroureter, hydronephrosis, renal failure and reduced bladder capacity. The specific diagnosis of UG-TB is achieved by culturing Mycobacterium tuberculosis from an appropriate clinical sample or by DNA identification. Imaging can aid in localizing site, extent and effect of the disease, obtaining tissue samples for diagnosis, planning medical or surgical management, and monitoring response to treatment. Drug-sensitive TB requires 6–9 months of WHO-recommended standard treatment regimens. Drug-resistant TB requires 12–24 months of therapy with toxic drugs with close monitoring. Surgical intervention as an adjunct to medical drug treatment is required in certain circumstances. Current challenges in UG-TB management include making an early diagnosis, raising clinical awareness, developing rapid and sensitive TB diagnostics tests, and improving treatment outcomes.
    [Show full text]
  • CELL INJURY (For First Year Medical Students in 3 Lectures)
    PATHOLOGY Chapter: CELL INJURY (for first year medical students in 3 lectures) [Topics: cell injury, free radical injury, necrosis and apoptosis, cellular accumulations, pathological calcification, adaptation to cell injuries] (lecture 2) DR. SUFIA HUSAIN ASSOCIATE PROF & CONSULTANT DEPARTMENT OF PATHOLOGY COLLEGE OF MEDICINE, KSU, RIYADH. SEPTEMBER 2019 REFERENCE: ROBBINS & COTRAN PATHOLOGY AND RUBIN’S PATHOLOGY Objectives for Cell Injury Chapter (3 lectures) The students should: A. Understand the concept of cells and tissue adaptation to environmental stress including the meaning of hypertrophy, hyperplasia, aplasia, atrophy, hypoplasia and metaplasia with their clinical manifestations. B. Is aware of the concept of hypoxic cell injury and its major causes. C. Understand the definitions and mechanisms of free radical injury. D. Knows the definition of apoptosis, tissue necrosis and its various types with clinical examples. E. Able to differentiate between necrosis and apoptosis. F. Understand the causes of and pathologic changes occurring in fatty change (steatosis), accumulations of exogenous and endogenous pigments (carbon, silica, iron, melanin, bilirubin and lipofuscin). G. Understand the causes of and differences between dystrophic and metastatic calcifications. Lecture 2 outline A. Types of necrosis : Coagulative, Liquefactive, Caseous, gangrenous, fibrinoid and fat necrosis. B. Apoptosis : definition, morphologic features, regulation of apoptosis C. CompArison between necrosis and apoptosis. Normal cell Stress/increased demand Adaptation e.g. hypertrophy Injurious stimuli e.g. hypoxia Unable to adapt Cell injury No more Persistent or injurious stimuli strong injurious stimuli injury is reversible 2 possibilities 1) tissue repair but with diminished capacity à impaired cell function complete repair 2) injury becomes irreversible àcell death (necrosis or apoptosis) Cells/ tissue back to normal Restoration of normal organ function.
    [Show full text]
  • Case Studies in Pathomorphology. Self Assessment Textbook. KROK
    MINISTRY OF PUBLIC HEALTH OF UKRAINE Case studies in Pathomorphology. Self assessment textbook. KROK – 1 (STEP – 1) Part - І Рекомендовано Центральним методичним кабінетом з вищої ме- дичної освіти МОЗ України як навчальний посібник для студен- тів вищих медичних навчальних закладів ІІІ-ІV рівня акредитації (протокол № 2 від 19.03.2010) All rights reserved. No part of this publication may be reproduced, stored in retrieved system, copied or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or oth- erwise without written permission from the author. 2 Pathology of cell. Parenchymal dystrophy. 1. During an autopsy a parenchymal fatty dystrophy of the myocardium was diag- nosed. What is the common or descriptive name of the heart due to this dystrophy? A. *‘Tabby cat‘ heart (‗Tiger‘s‘ heart) B. Bovine heart C. ‗Hairy‘ heart D. Solder plaque (bony heart) E. Cor pulmonale 2. A patient with leukemia died from severe chronic anemia. An autopsy revealed an enlarged heart, with flabby myocardium. It had a dim pale-grey color, yellow spots and bars. Which pathological process was found in the heart at post-mortem? A. * Parenchymal fatty dystrophy B. Vacuolar dystrophy. C. Hydropic dystrophy. D. Mesenchymal fatty dystrophy. E. Mixed dystrophy. 3. A 53 year old patient died with symptoms of liver insufficiency. A post-mortem examination revealed the enlarged, flabby, yellow-brown liver. Gross examination of the liver‘s section showed drops of fat. Microscopically: hepatocytes on the pe- ripheries of the hepatic lobules contained masses of small drops within the cytop- lasm. Which process most likely took place in the liver? A.
    [Show full text]
  • Mycobacterium Bovis : About a Case
    Canine tuberculosis due to Mycobacterium bovis : about a case SFAPV Histopathology Meeting – November 18th, 2010 Claire-Lise ETIENNE, resident in veterinary pathology Ecole Nationale Vétérinaire de Toulouse Identification of the case 4-year old dog Neutered Female Shepherd crossbreed 25 Kg In Tarn (81) In the countryside with neighboring farms Free to roam In contact with 2 cats History – Clinical findings 1 month ago : Abcess on right thigh treated with local sugery and antibiotics, anti-inflammatory drug 10-day history of : Polyadenomegaly and PuPd Anorexia, tiredness, loss weight, diarrhea Apyrexia (38.4 C) Neutrophilic leukocytosis, lymphopenia Hyperuremia, hypercreatininemia (x4) Hematology Blood smear Intracytoplasmic bacilli negatively stained with MGG In monocytes In neutrophils Acid-Fast Bacillus (AFB) consistent with mycobacterium Septicemic form x1000 MGG x1000 MGG x1000 MGG Cytology LN cytoponction Numerous macrophages Fat globules + calcification + Degenerated neutrophils degenerated neutrophils Pyogranulomatous adenitis Caseation necrosis x400 MGG Cytology LN cytoponction Extra and intracytoplasmic bacilli in macrophages and neutrophils Positive Ziehl-Neelsen stain Pyogranulomatous adenitis with infectious origin : Acid-Fast Bacillus x1000 MGG x1000 ZN Macroscopic Results Subcutaneous adipose tissue Glistening surface Marked subcutaneous edema Marked diffuse congestion Diffuse multiple extensive yellow and chalky foci Fatty necrosis with mineralization Severe necrotizing panniculitis Macroscopic
    [Show full text]
  • Caseous Necrosis in Cutaneous Leishmaniasis
    Evaluation of the LCR based assay for detecting C trachomatis 517 sensitivity of the LCR kit is identical with that results. Therefore, we recommend the LCR of the PCR kit and that the LCR kit can detect and PCR kits for the routine diagnosis of C tra- two or more EBs per assay. The average num- chomatis infection. ber of plasmids in one EB was estimated to be J Clin Pathol: first published as 10.1136/jcp.49.6.517 on 1 June 1996. Downloaded from This work was supported by Grants-in-Aid of Scientific about 10.' These results, therefore, indicate Research from the Ministry of Education, Science and Culture, that 20 copies or more of the plasmid can be Japan (63570204) and Project Research Grants, Kawasaki amplified and detected by the LCR kit under Medical School (6-506). 1 Cates W Jr, Wasserheit JN. Genital chalmydial infections: the conditions used. Dille et al' reported that epidemiology and reproductive sequelae. Am J Obstet the sensitivity of the LCR kit which targets the Gynecol 1991;164:1771-81. 2 Loeffelholz MJ, Lewinski CA, Silver SR, Purohit AP, major outer membrane protein gene and the Herman SA, Buonagurio DA, et al. Detection of Chlamy- plasmid appeared to be three EBs per assay dia trachomatis in endocervical specimens by polymerase chain reaction. J7 Clin Microbiol 1992;30:2847-51. using purified EBs which were counted by 3 Miyashita N, IijimaY, Matsumoto A. Evaluation of the sen- optical microscopy with Giemsa staining. sitivity and specificity ofpolymerase chain reaction test kit, AMPLICOR Chlamydia trachomatis.
    [Show full text]
  • 12.2% 108500 120M Top 1% 154 3700
    We are IntechOpen, the world’s leading publisher of Open Access books Built by scientists, for scientists 3,700 108,500 120M Open access books available International authors and editors Downloads Our authors are among the 154 TOP 1% 12.2% Countries delivered to most cited scientists Contributors from top 500 universities Selection of our books indexed in the Book Citation Index in Web of Science™ Core Collection (BKCI) Interested in publishing with us? Contact [email protected] Numbers displayed above are based on latest data collected. For more information visit www.intechopen.com 15 Pathology of HIV/AIDS: Lessons from Autopsy Series Andrey Bychkov1,2, Shunichi Yamashita1 and Alexander Dorosevich2 1Nagasaki University Graduate School of Biomedical Sciences 2Smolensk Regional Institute of Pathology 1Japan 2Russia 1. Introduction HIV infection is a global disease and despite considerable efforts of the international community it is a main cause of human mortality (UNAIDS, 2009). Morphological insights into HIV/AIDS are based on the study of clinical cases by means of biopsy and autopsy. Morphological changes during development of HIV infection and, especially, through AIDS progression are variable and specified mainly by characteristics of widespread secondary infections and tumors. Opportunistic infections account for approximately 80% of deaths in patients with AIDS and their spectrum is constantly changing, as a result of improvements in treatment options and prophylaxis along with the increasing life span of HIV-infected individuals. Postmortem examinations provide important diagnostic and epidemiological data and represent a most reliable source for estimation of the full spectrum of diseases in individual patients and the general population.
    [Show full text]